Cargando…
Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms
In 2009, vigabatrin became the first FDA approved medication for the treatment of infantile spasms in the United States. There are few well-designed prospective studies comparing the drug to placebo or other modalities used in the treatment of infantile spasms. The available data have demonstrated t...
Autores principales: | Faulkner, Michele A., Tolman, Justin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663614/ https://www.ncbi.nlm.nih.gov/pubmed/23861649 http://dx.doi.org/10.4137/JCNSD.S6371 |
Ejemplares similares
-
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
por: Tolman, Justin A, et al.
Publicado: (2011) -
Response to sequential treatment with prednisolone and vigabatrin in infantile spasms
por: Dzau, Winston, et al.
Publicado: (2022) -
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010) -
Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta‐analysis
por: Xu, Zhao, et al.
Publicado: (2023) -
Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study
por: Westall, Carol A., et al.
Publicado: (2014)